Stoke Therapeutics Inc buy Credit Suisse Group AG
Start price
08.08.23
/
50%
€4.88
Target price
08.08.24
€21.00
Performance (%)
172.54%
Price
26.07.24
€14.60
Summary
This prediction is currently active. With a performance of 172.54% the BUY prediction by Credit_Suisse_Group_ is a big success. This prediction currently runs until 08.08.24. The prediction end date can be changed by Credit_Suisse_Group_ at any time. Credit_Suisse_Group_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Stoke Therapeutics Inc | 16.800% | 16.800% |
iShares Core DAX® | 1.280% | 1.320% |
iShares Nasdaq 100 | -2.457% | -5.192% |
iShares Nikkei 225® | -2.006% | -1.389% |
iShares S&P 500 | -0.662% | -1.884% |
Comments by Credit_Suisse_Group_ for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "outperform" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $23.00 price target on the stock.
Ratings data for STOK provided by MarketBeat